---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-041556"
form_type: "8-K"
ticker: "MLTX"
cik: "0001821586"
company_name: "MoonLake Immunotherapeutics"
filed_at: "2023-05-19T23:59:59+00:00"
generated_at: "2026-06-14T20:01:10.359483+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MoonLake Immunotherapeutics amends equity plans to provide automatic vesting upon change of control

## Summary
- Effective May 15, 2023, Board amended Employee Share Participation Plan and Stock Option Plan to include single-trigger vesting upon Change of Control.
- Amendments apply to all outstanding and future equity awards, including those to named executive officers.
- Awards will vest in full automatically upon a Change of Control as defined in the Plans.
- Change aligns compensation arrangements with market practice per the Company's review.

## SEC filing metadata
- accession: 0001213900-23-041556
- form_type: 8-K
- ticker: MLTX
- cik: 0001821586
- company_name: MoonLake Immunotherapeutics
- filed_at: 2023-05-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821586/000121390023041556/0001213900-23-041556-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821586/000121390023041556/ea178889-8k_moonlake.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-041556
- JSON: https://secwatch.observer/filing/0001213900-23-041556.json
- Plain text: https://secwatch.observer/filing/0001213900-23-041556.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.